Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

Moving beyond our comfort zone

(2013) Brian Claggett et al.   EUROPEAN HEART JOURNAL

Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia

(2012) Sumeet Subherwal et al.   AMERICAN HEART JOURNAL

Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint

(2012) J. A. Bakal et al.   EUROPEAN HEART JOURNAL

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

(2012) Matthew T. Roe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Refining clinical trial composite outcomes: An application to the Assessment of the Safety and Efficacy of a New Thrombolytic–3 (ASSENT-3) trial

(2011) Paul W. Armstrong et al.   AMERICAN HEART JOURNAL

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

(2011) S. J. Pocock et al.   EUROPEAN HEART JOURNAL

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial

(2010) Chee Tang Chin et al.   AMERICAN HEART JOURNAL

Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis

(2010) Francesco Borgia et al.   EUROPEAN HEART JOURNAL